CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-18 | Curley Joanne Chief Development Officer | Option exercise | +1,078 | $6.37 | $7K | 28,887 |
| 2022-10-18 | Curley Joanne Chief Development Officer | Sale | −1,078 | $19.43 | $21K | 27,809 |
| 2022-10-18 | Curley Joanne Chief Development Officer | Option exercise | +2,212 | $2.90 | $6K | 30,021 |
| 2022-10-18 | Curley Joanne Chief Development Officer | Sale | −2,212 | $19.39 | $43K | 27,809 |
| 2022-10-18 | Curley Joanne Chief Development Officer | Option exercise | +5,298 | $11.00 | $58K | 33,107 |
| 2022-10-18 | Curley Joanne Chief Development Officer | Sale | −5,298 | $19.42 | $103K | 27,809 |
| 2022-10-18 | Curley Joanne Chief Development Officer | Option exercise | +2 | $11.00 | $22 | 27,811 |
| 2022-10-18 | Curley Joanne Chief Development Officer | Sale | −2 | $20.30 | $41 | 27,809 |
| 2022-10-18 | Curley Joanne Chief Development Officer | Option exercise · Stock Option (right to buy) | −1,078 | 10,795 | ||
| 2022-10-18 | Curley Joanne Chief Development Officer | Option exercise · Stock Option (right to buy) | −2,212 | 40,224 | ||
| 2022-10-18 | Curley Joanne Chief Development Officer | Option exercise · Stock Options (right to buy) | −5,300 | 84,017 | ||
| 2022-10-05 | Curley Joanne Chief Development Officer | Sale | −988 | $21.64 | $21K | 27,809 |
| 2022-10-04 | Fordyce Marshall President and CEO | Option exercise | +6,899 | $2.90 | $20K | 188,049 |
| 2022-10-04 | Fordyce Marshall President and CEO | Sale | −6,899 | $20.29 | $140K | 181,150 |
| 2022-10-04 | Fordyce Marshall President and CEO | Option exercise | +10,418 | $2.90 | $30K | 191,568 |
| 2022-10-04 | Fordyce Marshall President and CEO | Sale | −10,418 | $21.69 | $226K | 181,150 |
| 2022-10-04 | Fordyce Marshall President and CEO | Option exercise | +906 | $2.90 | $3K | 182,056 |
| 2022-10-04 | Fordyce Marshall President and CEO | Sale | −906 | $22.19 | $20K | 181,150 |
| 2022-10-04 | Fordyce Marshall President and CEO | Option exercise · Stock Option (Right to Buy) | −18,223 | 947,212 | ||
| 2022-10-03 | Fordyce Marshall President and CEO | Option exercise | +11,369 | $2.90 | $33K | 192,519 |
Page 20 of 30 · 581 trades